Advertisement

Acute Myeloid Leukemia

Disease State Hub

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

Featured

Conference Coverage
cc
Conference Coverage
Intrathecal Methotrexate Effective In CSF Clearance, Improving Neurologic Symptoms In AML Patients With CNS Involvement
09/29/2023

Anthony Calabro, MA

Anthony Calabro, MA
Researchers retrospectively identified patients with CNS AML and evaluated several treatments and outcomes for this type of cancer at two large academic institutions.
09/29/2023
Research Summary
rs
Research Summary
Blood Test Detects Residual Disease For Adults With AML in Remission Prior to Bone Marrow Transplant
09/20/2023

Anthony Calabro, MA

Anthony Calabro, MA
Researchers performed a retrospective observational study to determine whether DNA sequencing can detect residual disease in adults with acute myeloid leukemia (AML) in first remission.
09/20/2023
Video
headshot
Video
Microbiota Transplant Therapy Demonstrates Safety, Has No Effect on Infection for Patients with AML
09/13/2023

Alexander Khoruts, MD

Alexander Khoruts, MD
In this video, Alexander Khoruts, MD talks about his team's randomized, double-blind study, which showed that fecal microbiota transplant therapy is safe to use for patients with acute myeloid leukemia...
09/13/2023
Advertisement

Interactive Features

Pop Quiz
Pop Quiz
Pop Quiz
Genetic Mutations Associated With AML
08/29/2023
Do you know which genetic mutation is commonly associated with acute myeloid leukemia? Find out in our latest pop quiz!
08/29/2023
Pop Quiz
Kendall Diebold, DNP, FNP-C
Pop Quiz
Consolidation Cytarabine Administration in Adults With AML
08/10/2023
Do you know the primary purpose of consolidation cytarabine administration in the treatment of adults with acute myeloid leukemia, according to the poster discussion presented at ASCO 2023 titled "Outcomes...
08/10/2023
pop quiz
blood cells
pop quiz
Incidence of Acute Myeloid Leukemia
06/12/2023
Acute myeloid leukemia is one of the most common types of leukemia in adults, but what is the incidence of this type of leukemia among overall cases of cancer? Find out with this pop quiz.
06/12/2023
pop quiz
doctor with medical records
pop quiz
Common Symptoms of Acute Myeloid Leukemia
05/23/2023
Acute myeloid leukemia often causes symptoms rapidly. Are you familiar with common symptoms of acute myeloid leukemia? Take this pop quiz to find out.
05/23/2023

Clinical Insights

Video
headshot
Video
Microbiota Transplant Therapy Demonstrates Safety, Has No Effect on Infection for Patients with AML
09/13/2023

Alexander Khoruts, MD

Alexander Khoruts, MD
In this video, Alexander Khoruts, MD talks about his team's randomized, double-blind study, which showed that fecal microbiota transplant therapy is safe to use for patients with acute myeloid leukemia...
09/13/2023
Expert Q&A
Kendall Diebold, DNP, FNP-C
Expert Q&A
Safety, Efficacy of 3-day Administration Schedule of Consolidation Cytarabine in Adults With AML
08/21/2023

Kendall Diebold, DNP, FNP-C

Kendall Diebold, DNP, FNP-C
Consolidation therapy with intermediate- to high-dose cytarabine is crucial in the prevention of acute myeloid leukemia relapse.1 In this Q&A, Kendall Diebold, DNP, FNP-C, answers questions about her...
08/21/2023
Video
Ian Bouligny
Video
Venetoclax-based Strategies in Patients With Secondary-Type Mutations, Acute Myeloid Leukemia
07/25/2023

Ian Bouligny, MD

Ian Bouligny, MD
In this video, Ian Bouligny, MD, discusses his team’s research that aimed to determine the impact of secondary-type mutations in patients who were newly diagnosed with acute myeloid leukemia and treated...
07/25/2023
Conference Coverage
Kendall Diebold, DNP, FNP-C
Conference Coverage
Administration Schedule of Consolidation Cytarabine in Adults With Acute Myeloid Leukemia
07/17/2023

Kendall Diebold, NP

Kendall Diebold, NP
In this video, Kendall Diebold, DNP, FNP-C, speaks about her team’s research titled “Outcomes of 3- Versus 5-Day Administration Schedule of Consolidation Cytarabine in Adults with Acute Myeloid Leukemia,”...
07/17/2023
Expert Q&A
Ian Bouligny
Expert Q&A
Can Venetoclax-Based Strategies Be Used in Treating Patients With Seoncdary-Type AML Mutations?
08/21/2015

Ian Bouligny, MD

Ian Bouligny, MD
In this Q&A, Ian Bouligny, MD, answers questions about his team’s research that sought to determine the use of venetoclax-based strategies in patients with newly diagnosed secondary-type mutations of...
08/21/2015